Literature DB >> 2694500

A mixed infection of vivax and falciparum malaria apparently resistant to 4-aminoquinoline: a case report.

G J Schuurkamp1, P E Spicer, R K Kereu, P K Bulungol.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2694500     DOI： 10.1016/0035-9203(89)90370-2

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  9 in total

Review 1.  The evolution of tafenoquine--antimalarial for a new millennium?

Authors:  W Peters
Journal:  J R Soc Med       Date:  1999-07       Impact factor: 5.344

2.  Susceptibility to chloroquine, mefloquine and artemisinin of Plasmodium vivax in northwestern Thailand.

Authors:  Birgit Woitsch; Gunther Wernsdorfer; Kanungnit Congpuong; Chaiporn Rojanawatsirivet; Jeeraphat Sirichaisinthop; Walther H Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

3.  In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.

Authors:  A R Hasugian; E Tjitra; A Ratcliff; H Siswantoro; E Kenangalem; R M Wuwung; H L E Purba; K A Piera; F Chalfien; J Marfurt; P M Penttinen; B Russell; N M Anstey; R N Price
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

4.  The pharmacokinetics of chloroquine in healthy Thai subjects and patients with Plasmodium vivax malaria.

Authors:  K Na-Bangchang; L Limpaibul; A Thanavibul; P Tan-Ariya; J Karbwang
Journal:  Br J Clin Pharmacol       Date:  1994-09       Impact factor: 4.335

Review 5.  In vitro drug sensitivity testing in Plasmodium vivax.

Authors:  Walther H Wernsdorfer; Oumaporn Tasanor; Gunther Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

6.  Monitoring of clinical efficacy and in vitro sensitivity of Plasmodium vivax to chloroquine in area along Thai Myanmar border during 2009-2010.

Authors:  Poonuch Muhamad; Ronnatrai Ruengweerayut; Wanna Chacharoenkul; Kanchana Rungsihirunrat; Kesara Na-Bangchang
Journal:  Malar J       Date:  2011-02-16       Impact factor: 2.979

7.  Confirmed Plasmodium vivax Resistance to Chloroquine in Central Vietnam.

Authors:  Pham Vinh Thanh; Nguyen Van Hong; Nguyen Van Van; Melva Louisa; Kevin Baird; Nguyen Xuan Xa; Koen Peeters Grietens; Le Xuan Hung; Tran Thanh Duong; Anna Rosanas-Urgell; Niko Speybroeck; Umberto D'Alessandro; Annette Erhart
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

8.  Population pharmacokinetics of a three-day chloroquine treatment in patients with Plasmodium vivax infection on the Thai-Myanmar border.

Authors:  Richard Höglund; Younis Moussavi; Ronnatrai Ruengweerayut; Anurak Cheomung; Angela Äbelö; Kesara Na-Bangchang
Journal:  Malar J       Date:  2016-02-29       Impact factor: 2.979

9.  Significant geographical differences in prevalence of mutations associated with Plasmodium falciparum and Plasmodium vivax drug resistance in two regions from Papua New Guinea.

Authors:  Céline Barnadas; Lincoln Timinao; Sarah Javati; Jonah Iga; Elisheba Malau; Cristian Koepfli; Leanne J Robinson; Nicolas Senn; Benson Kiniboro; Lawrence Rare; John C Reeder; Peter M Siba; Peter A Zimmerman; Harin Karunajeewa; Timothy M Davis; Ivo Mueller
Journal:  Malar J       Date:  2015-10-09       Impact factor: 2.979
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.